← Back to Search

Expiratory Muscle Strength Training + Voice Therapy for Vocal Cord Paralysis

N/A

Waitlist Available

Led By Adam T Lloyd, SLP-D, MM, MA

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adequate cognition evidenced by score of 24 or higher on the Mini-Mental State Examination (MMSE) survey to determine if the subject has the mental capacity to participate in therapy

Completed voice combination evaluation with speech pathologists and otolaryngologist

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 16 weeks

Awards & highlights

Study Summary

This trial will determine if adding expiratory muscle strength training to traditional voice therapy improves outcomes for people with dysphonia due to glottal insufficiency.

Who is the study for?

This trial is for adults over 18 with glottal insufficiency, who've seen a speech pathologist and otolaryngologist. They must score at least 24 on the MMSE, showing they can follow therapy instructions. It's not for those unable to consent, non-English/Spanish speakers, pregnant women, prisoners, or people with certain medical conditions like uncontrolled blood pressure or chronic respiratory diseases.Check my eligibility

What is being tested?

The study tests if adding expiratory muscle strength training (EMST) to standard voice therapy improves breathing strength and voice quality in individuals with vocal cord issues. The goal is to see better maximal expiratory pressure and voice measures such as loudness and duration of sound.See study design

What are the potential side effects?

Potential side effects from EMST may include discomfort while using the device or fatigue due to the exercises. Standard voice therapy generally has minimal risks but could also cause temporary vocal strain or fatigue.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My mental ability to participate in therapy is confirmed by a test score.

Select...

I have completed a voice check with speech and throat specialists.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 16 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~16 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Amplitude

Maximum expiratory pressure

Secondary outcome measures

Cepstral Peak Prominence (CPP)

Cepstral spectral index of dysphonia (CSID)

Dynamic pitch range

+4 more

Trial Design

3Treatment groups

Experimental Treatment

Group I: Unilateral vocal fold paralysis standard of care voice therapyExperimental Treatment1 Intervention

The participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques.

Group II: Unilateral paralysis standard of care voice therapy plus EMSTExperimental Treatment2 Interventions

The participants will receive the standard of voice therapy including improved breath coordination, sustained humming and vowels, vocal glides, resonant voice therapy, and relations techniques. EMST consists of blowing into respiratory device at a measure threshold pressure. As strength improves threshold resistance will be increased.

Group III: Parkinson's disease standard of care voice therapy plus EMSTExperimental Treatment2 Interventions

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor

899 Previous Clinical Trials

409,612 Total Patients Enrolled

Adam T Lloyd, SLP-D, MM, MAPrincipal InvestigatorUniversity of Miami

Media Library

Standard of Care Voice Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03692494 — N/A

Hoarseness Research Study Groups: Unilateral paralysis standard of care voice therapy plus EMST, Unilateral vocal fold paralysis standard of care voice therapy, Parkinson's disease standard of care voice therapy plus EMST

Hoarseness Clinical Trial 2023: Standard of Care Voice Therapy Highlights & Side Effects. Trial Name: NCT03692494 — N/A

Standard of Care Voice Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03692494 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently recruiting participants for this trial?

"Resources on clinicaltrials.gov specify that this particular medical trial is not currently recruiting, with the initial post coming in January 1st 2023 and last update dated to May 26th 2022. On a brighter note, there are 112 other studies presently seeking potential participants."

Answered by AI

What is the primary goal of this research endeavor?

"This 16-week clinical trial aims to assess Maximum Expiratory Pressure (MEP). Secondary research objectives include measuring Fundamental Frequency, Dynamic Pitch Range, and Cepstral Peak Prominence using the Analysis of Dysphonia in Speech and Voice on Kay Pentax Computerised Speech Lab."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy

Adam Lloyd 2024. "The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03692494.